1 / 40

Chapter 3 Death and Survival on Dialysis

Chapter 3 Death and Survival on Dialysis. Wong Hin Seng Ong Loke Meng. Source: 20 th MDTR Report 2012, NRR. Table 3.1.1: Deaths on dialysis 1993-2012. Source: 20 th MDTR Report 2012, NRR. Annual death rate on PD. Annual death rate on HD. 20. 15. Death rate. 10. 5. 0. '93. '94.

morley
Download Presentation

Chapter 3 Death and Survival on Dialysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chapter 3Death and Survival on Dialysis Wong Hin Seng Ong Loke Meng Source: 20th MDTR Report 2012, NRR

  2. Table 3.1.1: Deaths on dialysis 1993-2012 Source: 20th MDTR Report 2012, NRR

  3. Annual death rate on PD Annual death rate on HD 20 15 Death rate 10 5 0 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05 '06 '07 '08 '09 '10 '11 '12 Year Figure 3.1.1: Death rates on dialysis 1993-2012 Source: 20th MDTR Report 2012, NRR

  4. Table 3.1.2 (a) : Causes of death on HD dialysis 1994-2012 Source: 20th MDTR Report 2012, NRR

  5. Table 3.1.2 (b) : Causes of death on PD dialysis 1993-2012 Source: 20th MDTR Report 2012, NRR

  6. Table 3.2.1(a): HD Patient survival (censored for change of modality) Source: 20th MDTR Report 2012, NRR

  7. Table 3.2.1(b): PD Patient survival (censored for change of modality) Source: 20th MDTR Report 2012, NRR

  8. Table 3.2.1(c): HD Patient survival (not censored for change of modality) Source: 20th MDTR Report 2012, NRR

  9. Table 3.2.1(d): PD Patient survival (not censored for change of modality) Source: 20th MDTR Report 2012, NRR

  10. Table 3.2.2(a): Unadjusted HD patient survival by year of entry, 1993-2012 Source: 20th MDTR Report 2012, NRR

  11. Figure 3.2.2(a): Unadjusted HD patient survival by year of entry, 1993-2012 Source: 20th MDTR Report 2012, NRR

  12. Table 3.2.2(b): Unadjusted PD patient survival by year of entry, 1993-2012 Source: 20th MDTR Report 2012, NRR

  13. Figure 3.2.2(b): Unadjusted PD patient survival by year of entry, 1993-2012 Source: 20th MDTR Report 2012, NRR

  14. Table 3.2.3(a): Unadjusted HD patient survival by age, 1993-2012 Source: 20th MDTR Report 2012, NRR

  15. Figure 3.2.3(a): Unadjusted HD patient survival by age, 1993-2012 Source: 20th MDTR Report 2012, NRR

  16. Table 3.2.3(b): Unadjusted PD patient survival by age, 1993-2012 Source: 20th MDTR Report 2012, NRR

  17. Figure 3.2.3(b): Unadjusted PD patient survival by age, 1993-2012 Source: 20th MDTR Report 2012, NRR

  18. Table 3.2.4(a): Unadjusted HD patient survival by diabetes mellitus status, 1993-2012 Source: 20th MDTR Report 2012, NRR

  19. Figure 3.2.4(a): Unadjusted HD patient survival by diabetes mellitus status, 1993-2012 Source: 20th MDTR Report 2012, NRR

  20. Table 3.2.4(b): Unadjusted PD patient survival by diabetes mellitus status, 1993-2012 Source: 20th MDTR Report 2012, NRR

  21. Figure 3.2.4(b): Unadjusted PD patient survival by diabetes mellitus status, 1993-2012 Source: 20th MDTR Report 2012, NRR

  22. Figure 3.3.1(a): Variation in patient survival at 1-year among HD centres adjusted for age and diabetes mellitus status, 1993-2011 *Horizontal line represents the median % survival among HD centres Source: 20th MDTR Report 2012, NRR

  23. Figure 3.3.1(b): Funnel plot for adjusted age at 1-year among HD centres adjusted for age and diabetes mellitus status, 1993-2011cohor *Horizontal line represents the mean % survival among HD centres Source: 20th MDTR Report 2012, NRR

  24. Figure 3.3.1(c): Variation in patient survival at 5-years among HD centres adjusted for age and diabetes mellitus status, 1993-2007 *Horizontal line represents the median % survival among HD centres Source: 20th MDTR Report 2012, NRR

  25. Figure 3.3.1(d): Funnel plot for patient survival at 5-years among HD centres adjusted age and diabetes mellitus, 1993-2007cohort *Horizontal line represents the mean % survival among HD centres Source: 20th MDTR Report 2012, NRR

  26. Figure 3.3.2(a): Variation in patient survival at 1-year among PD centres adjusted for age and diabetes mellitus , 1993-2011 *Horizontal line represents the median% survival among PD centres Source: 20th MDTR Report 2012, NRR

  27. Figure 3.3.2(b): Funnel plot of 1-year patient survival from the 90th day of dialysis adjusted for age and diabetes mellitus among PD centres, 1993-2011 cohort *Horizontal line represents the mean % survival among PD centres Source: 20th MDTR Report 2012, NRR

  28. Figure 3.3.2(c): Variation in patient survival at 5-years among PD centres adjusted for age and diabetes mellitus, 1993-2007 *Horizontal line represents the mean % survival among PD centres Source: 20th MDTR Report 2012, NRR

  29. Figure 3.3.2(d): Funnel plot of 5-years patient survival from 90 day of dialysis adjusted for age and diabetes mellitus among PD centres, 1993-2007 cohort *Horizontal line represents the median% survival among PD centres Source: 20th MDTR Report 2012, NRR

  30. Table 3.4.1: Adjusted hazard ratio for mortality of dialysis patients (not censored for change of modality (1993-2012) )

  31. Diastolic Blood Pressure (mmHg) 2 1.73 1.5 1.15 Hazard ratio 1.01 1 1 .78 .5 0 <70 70-<80 80-<90(ref*) 90-<100 >=100 Figure 3.4.1(a): Adjusted hazard ratio for mortality of dialysis patients uncensored for change of modality by diastolic blood pressure (1993-2012 cohort) Source: 20th MDTR Report 2012, NRR

  32. Serum Phosphate (mmol/L) 1.59 1.5 1 1 .88 .83 Hazard ratio .82 .5 0 <0.8 0.8-1.3(ref*) 1.3-1.8 1.8-2.2 >=2.2 Figure 3.4.1(b): Adjusted hazard ratio for mortality of dialysis patients uncensored for change of modality by serum phosphate (1993-2012 cohort) Source: 20th MDTR Report 2012, NRR

  33. Calcium Phosphate Product (mmol2/L2) 1.11 1 1 .82 .77 Hazard ratio .5 0 <3.5 3.5-<4.5 (ref*) 4.5-<5.5 >=5.5 Figure 3.4.1(c): Adjusted hazard ratio for mortality of dialysis patients uncensored for change of modality by hemoglobin (1993-2012 cohort) Source: 20th MDTR Report 2012, NRR

  34. Table 3.4.2: Adjusted hazard ratio for mortality of HD patients uncensored for change of modality (1993-2012 cohort)

  35. Prescribed KT/V-HD 1.5 1.35 1.15 1.11 1 .96 1 Hazard ratio .5 0 <1 1-<1.2 1.2-<1.4(ref*) 1.4-<1.6 >=1.6 Figure 3.4.2: Adjusted hazard ratio for mortality of HD patients uncensored for change of modality by Prescribed Kt/V (1993-2012 cohort) Source: 20th MDTR Report 2012, NRR

  36. Table 3.4.3: Adjusted hazard ratio for mortality of PD patients uncensored for change of modality (1993-2012 cohort)

  37. Figure 3.4.4(a): Variations in RAMR by HD centre, 2011 Source: 20th MDTR Report 2012, NRR

  38. Figure 3.4.4(b): Funnel plot of RAMR by HD centre, 2011 Source: 20th MDTR Report 2012, NRR

  39. Figure 3.4.5(a): Variations in RAMR by PD centres, 2011 Source: 20th MDTR Report 2012, NRR

  40. Figure 3.4.5(b): Funnel plot for RAMR by PD centres, 2011 Source: 20th MDTR Report 2012, NRR

More Related